Preparation and characterization of highly stable lipid nanoparticles with amorphous core of tuneable viscosity.

Lipid nanoparticles (LNP) have been designed based on low cost and human-use approved excipients, and manufactured by an easy, robust, and up-scalable process. Fluid colloidal dispersions or gel viscous formulations of highly stable nanoparticles (more than 12 month stability is achieved for some formulations) can be obtained. Their physicochemical properties are studied by Dynamic Light Scattering, Differential Scanning Calorimetry, and NMR. The results picture nanoparticles with a non-crystalline core, which viscosity can be finely tuned by the lipid composition and the temperature. A design of experiments has been used to investigate the limits of the system colloidal stability. The impact of core and surfactant weight fractions have been explored both experimentally and using the design of experiments. The versatility of this physicochemical system could open the way to a wide range of future pharmaceutical applications.

[1]  Michihiro Nakamura,et al.  Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles , 2007, International journal of cancer.

[2]  P. Walstra,et al.  Transfer of Oil between Emulsion Droplets , 1996, Journal of colloid and interface science.

[3]  R. Müller,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[4]  J. Swarbrick.  Drugs and the pharmaceutical sciences , 1975 .

[5]  H. Bunjes,et al.  Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential , 1997 .

[6]  R. Müller,et al.  Solid lipid nanoparticles for parenteral drug delivery. , 2004, Advanced drug delivery reviews.

[7]  Vladimir P. Torchilin,et al.  Nanoparticulates as Drug Carriers , 2006 .

[8]  N. Major.  Drugs and the pharmaceutical sciences, Vol 84, pharmaceutical enzymes , 1999 .

[9]  K. Mäder,et al.  Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.

[10]  T. Tadros,et al.  Formation and stability of nano-emulsions. , 2004, Advances in colloid and interface science.

[11]  P. Cochat,et al.  Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[12]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[13]  Thomas Delmas,et al.  How to prepare and stabilize very small nanoemulsions. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[14]  Arvid Wretlind,et al.  Invited Review: Development of Fat Emulsions , 1981 .

[15]  Isabelle Texier,et al.  Cyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging. , 2009, Journal of biomedical optics.

[16]  Rainer H Müller,et al.  Lipid nanoparticles for parenteral delivery of actives. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  S. Doktorovová,et al.  Nanostructured lipid carrier-based hydrogel formulations for drug delivery: A comprehensive review , 2009 .

[18]  R. Müller,et al.  Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles. , 2001, International journal of pharmaceutics.

[19]  C. Gourdon,et al.  Emulsification by ultrasound: drop size distribution and stability. , 1999, Ultrasonics sonochemistry.

[20]  Claire Mantel,et al.  Combined NMR and DFT studies for the absolute configuration elucidation of the spore photoproduct, a UV-induced DNA lesion. , 2008, Journal of the American Chemical Society.

[21]  R. Müller,et al.  Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  M. Povey,et al.  The effect of partial glycerides on trilaurin crystallization , 1997 .

[23]  Kiyotaka Sato.  Crystallization behaviour of fats and lipids — a review , 2001 .

[24]  R. Müller,et al.  Investigation on the viscoelastic properties of lipid based colloidal drug carriers. , 2000, International journal of pharmaceutics.

[25]  M. Martín-Pastor,et al.  Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[26]  Bryce J Marquis,et al.  Toxicity of therapeutic nanoparticles. , 2009, Nanomedicine.

[27]  R. Müller,et al.  Nanostructured lipid matrices for improved microencapsulation of drugs. , 2002, International journal of pharmaceutics.

[28]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[29]  G. Gerbaud,et al.  Microscopic structure of heterogeneous lipid-based formulations revealed by 13C high-resolution solid-state and 1H PFG NMR methods. , 2010, Chemistry and physics of lipids.

[30]  M. Bardet,et al.  Discrimination of 13C NMR signals in solid material with liquid-like behavior presenting residual dipolar proton-proton homonuclear interactions: application on seeds. , 2003, Journal of magnetic resonance.

[31]  Jean-Luc Coll,et al.  Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  Thomas D. Dziubla,et al.  PEGylation of nanocarrier drug delivery systems: State of the art , 2008 .

[33]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[34]  R. Müller,et al.  Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[35]  Karsten Mäder,et al.  Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[36]  W Mehnert,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[37]  M. Garcia‐Fuentes,et al.  Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures. , 2005, Journal of colloid and interface science.

[38]  Heike Bunjes,et al.  Crystallization tendency and polymorphic transitions in triglyceride nanoparticles , 1996 .